UPDATE -- AIT Therapeutics to Demonstrate NO Generator and Delivery System at Pediatric Academic Societies Meeting in Baltimore, MD on April 27-30

Apr 23, 2019 12:01pm EDT

AIT Therapeutics to Demonstrate NO Generator and Delivery System at Pediatric Academic Societies Meeting in Baltimore, MD on April 27-30

Apr 23, 2019 8:30am EDT

AIT Therapeutics to Participate at Two Investor Conferences in March

Mar 13, 2019 8:00am EDT

AIT Therapeutics Reports Financial Results for Fiscal Third Quarter 2019

Feb 13, 2019 4:05pm EST

AIT Therapeutics Announces Appointment of Robert F. Carey to Board of Directors

Feb 11, 2019 8:30am EST

AIT Therapeutics Schedules Fiscal Third Quarter 2019 Financial Results Conference Call and Webcast

Feb 05, 2019 4:15pm EST

AIT Receives $3.15 Million Milestone Payment from Commercialization Partner Circassia Pharmaceuticals

Feb 04, 2019 8:00am EST

AIT Enters into $32.5 million Commercial Licensing Agreement with Circassia Pharmaceuticals for Its Novel Nitric Oxide Generator and Delivery System for Use in the Hospital Setting in the United States and China

Jan 24, 2019 7:00am EST

AIT Strengthens Executive Leadership Team with Appointment of Chief Commercial Officer

Jan 02, 2019 8:30am EST

AIT Nearing Definitive Agreement to License Commercial Rights of Its Novel Ventilator Compatible Nitric Oxide Generator and Delivery System for Use in the Hospital Setting in the United States and a Second Country

Dec 28, 2018 4:56pm EST